The DOI matches its Crossref record; 81 of the 82 references it cites were found in a registry or an index.
Cellular Fatty Acid Metabolism and Cancer
Open accessAbstract
Cancer cells often have characteristic changes in metabolism. Cellular proliferation, a common feature of all cancers, requires fatty acids for synthesis of membranes and signaling molecules. Here, we provide a view of cancer cell metabolism from a lipid perspective, and we summarize evidence that limiting fatty acid availability can control cancer cell proliferation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For example, expression of ACLY, a key enzyme in the shift from the TCA cycle to lipid formation that has been shown to cause lipid droplet accumulation42, is significantly higher in LDAM than in microglia without lipid droplets.”
From Lipid-droplet-accumulating microglia represent a dysfunctional and proinflammatory state in the aging brain (2020) · cites this paper as [42]
Experimental — accuracy not yet measuredIn the citing paper
“Fatty acid synthesis is an anabolic process that uses cytosolic citrate to produce acetyl-CoA73.”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [73]
In the citing paper
“Next, mitochondrial citrate is transported across the inner mitochondrial membrane via a citrate carrier (CIC or SLC25A1) to support fatty acid synthesis for tumor progression in hypoxia73 (Fig. 4).”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [73]
In the citing paper
“PHD3 is suppressed in cancers that rely on FAO, such as AML and prostate cancer, and elevated in cancers that rely on FAS such as breast and non-small-lung-cell cancer.55–57”
From The multifaceted contributions of mitochondria to cellular metabolism (2018) · cites this paper as [56]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Warburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
Horton, J. D., Goldstein, J. L., & Brown, M. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15593 · Cited by 4,794
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
Horton, J. D., Goldstein, J. L., & Brown, M. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215593 · Cited by 4,092
Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis
Menendez, J. A., & Lupu, R. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2222 · Cited by 2,941
DeBerardinis, R. J., Mancuso, A., Daikhin, E., Nissim, I., Yudkoff, M., Wehrli, S., & Thompson, C. B. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709747104 · Cited by 2,622
Cancer cell metabolism: warburg and beyond
Hsu, P. P., & Sabatini, D. M. (2008) · Cell · doi:10.1016/j.cell.2008.08.021 · Cited by 2,452 · cited 1×
“A better understanding of these metabolic changes has prompted new approaches toward cancer therapy (reviewed in Hsu and Sabatini, 2008; Schulze and Harris, 2012).”
BackgroundATP-citrate lyase links cellular metabolism to histone acetylation
Wellen, K. E., Hatzivassiliou, G., Sachdeva, U. M., Bui, T. V., Cross, J. R., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1164097 · Cited by 2,298
Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth
Nieman, K. M., Kenny, H. A., Penicka, C. V., Ladanyi, A., Buell-Gutbrod, R., Zillhardt, M. R., Romero, I. L., Carey, M. S., Mills, G. B., Hotamisligil, G. S., et al. (2011) · Nature Medicine · doi:10.1038/nm.2492 · Cited by 2,279
Wise, D. R., DeBerardinis, R. J., Mancuso, A., Sayed, N., Zhang, X.-Y., Pfeiffer, H. K., Nissim, I., Daikhin, E., Yudkoff, M., McMahon, S. B., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810199105 · Cited by 2,001
Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia
Metallo, C. M., Gameiro, P. A., Bell, E. L., Mattaini, K. R., Yang, J., Hiller, K., Jewell, C. M., Johnson, Z. R., Irvine, D. J., Guarente, L., et al. (2012) · Nature · doi:10.1038/nature10602 · Cited by 1,791
Flagged first, then by citations
1 of the 82 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 801–900 of 1,000
The biological function of tumor-derived extracellular vesicles on metabolism
Fu, X., Song, J., Yan, W., Downs, B. M., Wang, W., & Li, J. (2023) · Cell Communication and Signaling · doi:10.1186/s12964-023-01111-6 · Cited by 30
Zhang, Y., Chen, P., Zhang, C., Wang, Y., Wang, P., Chen, Y., Wang, J., Hu, Y. C., Liu, C., Liang, H., et al. (2023) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-023-04891-9 · Cited by 29
Lipid profile in breast cancer: From signaling pathways to treatment strategies
Ribas, H. T., Sogayar, M. C., Dolga, A. M., Winnischofer, S. M. B., & Trombetta-Lima, M. (2023) · Biochimie · doi:10.1016/j.biochi.2023.11.008 · Cited by 29
Lipid metabolism dynamics in cancer stem cells: potential targets for cancers
Du, J., & Qin, H. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1367981 · Cited by 31
Epithelial-mesenchymal transition promotes metabolic reprogramming to suppress ferroptosis
Guo, W., Duan, Z., Wu, J., & Zhou, B. P. (2025) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2025.02.013 · Cited by 33
Hung, Y.-H., Huang, H.-L., Chen, W.-C., Yen, M., Cho, C.-Y., Weng, T., Wang, C., Chen, Y., Chen, L., & Lai, M.-D. (2016) · Oncology Reports · doi:10.3892/or.2016.5334 · Cited by 28
Systematic Analysis of Fatty Acids in Human Cells with a Multiplexed Isobaric Tag (TMT)-Based Method
Sun, F., Choi, A. A., & Wu, R. (2018) · Journal of Proteome Research · doi:10.1021/acs.jproteome.7b00896 · Cited by 28
MYCN and PRC1 cooperatively repress docosahexaenoic acid synthesis in neuroblastoma via ELOVL2
Ding, Y., Yang, J., Ma, Y., Yao, T., Chen, X., Ge, S., Wang, L., & Fan, X. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1492-5 · Cited by 29
DDX5 promotes oncogene C3 and FABP1 expressions and drives intestinal inflammation and tumorigenesis
Abbasi, N., Long, T., Li, Y., Yee, B. A., Cho, B. S., Hernandez, J. E., Ma, E., Patel, P. R., Sahoo, D., Sayed, I. M., et al. (2020) · Life Science Alliance · doi:10.26508/lsa.202000772 · Cited by 28
Wang, Y., Pan, H., chen, D., Guo, D., & Wang, X. (2021) · Journal of Functional Foods · doi:10.1016/j.jff.2021.104570 · Cited by 29
More Than Meets the Eye Regarding Cancer Metabolism
Kubicka, A., Matczak, K., & Łabieniec-Watała, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179507 · Cited by 31
Bai, X., Ali, A., Wang, N., Liu, Z., Lv, Z., Zhang, Z., Zhao, X., Hao, H., Zhang, Y., & Rahman, F. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113920 · Cited by 27
Muralidharan, S., Sahoo, S., Saha, A., Chandran, S., Majumdar, S. S., Mandal, S., Levine, H., & Jolly, M. K. (2022) · Biomolecules · doi:10.3390/biom12020297 · Cited by 27
Granit, A., Mishra, K., Barasch, D., Peretz-Yablonsky, T., Eyal, S., & Kakhlon, O. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.1014798 · Cited by 28
A review on the role of fatty acids in colorectal cancer progression
Hoxha, M., & Zappacosta, B. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1032806 · Cited by 29
Zhou, B., Wu, Y., Cheng, P., & Wu, C. (2023) · Molecular Oncology · doi:10.1002/1878-0261.13424 · Cited by 28
Pan, T., Zhang, M., Zhang, F., Yan, G., Ru, Y., Wang, Q., Zhang, Y., Wei, X., Xu, X., Shen, L., et al. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.01.018 · Cited by 26
Gopal, R., Selvarasu, K., Pandian, P. P., & Ganesan, K. (2017) · Cellular Oncology · doi:10.1007/s13402-017-0321-0 · Cited by 27
Rawling, T., Choucair, H., Koolaji, N., Bourget, K., Allison, S. E., Chen, Y., Dunstan, C. R., & Murray, M. T. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00701 · Cited by 28
Bernier‐Graveline, A., Lesage, V. S., Cabrol, J., Lair, S., Michaud, R., Rosabal, M., & Jonathan Verreault, A. (2020) · Environmental Research · doi:10.1016/j.envres.2020.110272 · Cited by 28
A Sterol-PI(4)P Exchanger Controls the Tel1/ATM Axis of the DNA Damage Response
Ovejero, S., Kumanski, S., Soulet, C., Azarli, J., Pardo, B., Santt, O., Constantinou, A., Pasero, P., & Moriel‐Carretero, M. (2022) · The EMBO Journal · doi:10.15252/embj.2022112684 · Cited by 24
Metformin Decouples Phospholipid Metabolism in Breast Cancer Cells
Smith, T., & Phyu, S. M. (2016) · PLoS ONE · doi:10.1371/journal.pone.0151179 · Cited by 27
The contrary intracellular and extracellular functions of PEDF in HCC development
Li, C., Huang, Z., Zhu, L., Yu, X., Gao, T., Feng, J., Hong, H., Yin, H., Zhou, T., Qi, W., et al. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1976-4 · Cited by 26
A Mouse Homolog of a Human TP53 Germline Mutation Reveals a Lipolytic Activity of p53
Kang, J., Lago, C. U., Lee, J., Park, J., Donnelly, M. P., Starost, M. F., Liu, C., Kwon, J., Noguchi, A. C., Ge, K., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2019.12.074 · Cited by 27
Temozolomide Treatment Increases Fatty Acid Uptake in Glioblastoma Stem Cells
Caragher, S. P., Miska, J. M., Shireman, J. M., Park, C. H., Muroski, M. E., Lesniak, M. S., & Ahmed, A. U. (2020) · Cancers · doi:10.3390/cancers12113126 · Cited by 27
Identification of the miRNA signature and key genes in colorectal cancer lymph node metastasis
Wang, X., Gao, G., Chen, Z., Chen, Z., Han, M., Xie, X., Jin, Q., Du, H., Cao, Z., & Zhang, H. (2021) · Cancer Cell International · doi:10.1186/s12935-021-02058-9 · Cited by 27
STARD3: A Prospective Target for Cancer Therapy
Asif, K., Memeo, L., Palazzolo, S., Frión-Herrera, Y., Parisi, S., Caligiuri, I., Canzonieri, V., Granchi, C., Tuccinardi, T., & Rizzolio, F. (2021) · Cancers · doi:10.3390/cancers13184693 · Cited by 30
Zhong, X., Yang, Y., Li, B., Liang, P., Huang, Y., Zheng, Q., Wang, Y., Xiao, X., Mo, Y., Zhang, Z., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2021.780410 · Cited by 27
Unraveling the Role of STK11/LKB1 in Non-small Cell Lung Cancer
Sumbly, V., & Landry, I. (2022) · Cureus · doi:10.7759/cureus.21078 · Cited by 30
Tolstik, T. V., Marquardt, C., Beleites, C., Matthäus, C., Bielecki, C., Bürger, M., Krafft, C., Dirsch, O., Settmacher, U., Popp, J., et al. (2014) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-014-1818-9 · Cited by 27
Yang, X., Sun, D., Dong, C., Tian, Y., Gao, Z., & Wang, L. (2016) · Oncotarget · doi:10.18632/oncotarget.9233 · Cited by 27
Spectroscopic analysis of normal and neoplastic (WI-FTC) thyroid tissue
Depciuch, J., Stanek‐Widera, A., Lange, D., Biskup-Frużyńska, M., Stanek-Tarkowska, J., Czarny, W., & Cebulski, J. (2018) · Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy · doi:10.1016/j.saa.2018.06.010 · Cited by 27
Lipopeptisomes: Anticancer peptide-assembled particles for fusolytic oncotherapy
Aronson, M. R., Simonson, A. W., Orchard, L., Llinás, M., & Medina, S. H. (2018) · Acta Biomaterialia · doi:10.1016/j.actbio.2018.09.025 · Cited by 27
Pouyafar, A., Heydarabad, M. Z., Aghdam, S. B., Khaksar, M., Azimi, A., Rahbarghazi, R., & Talebi, M. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.28129 · Cited by 27
Lipid metabolism reprogramming in head and neck cancer
Liang, J., Lin, L., Li, L., Zhou, X., Zhang, Z., Huang, Y., & Xiao, X. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1271505 · Cited by 26
Sun, S., Xu, H., Zhao, W., Li, Q., Yuan, Y., Zhang, G., Li, S., Wang, B., Zhang, W., Gao, X., et al. (2023) · Cancer Letters · doi:10.1016/j.canlet.2023.216511 · Cited by 28
Lombardi, M., Scaroni, F., Gabrielli, M., Raffaele, S., Bonfanti, E., Filipello, F., Giussani, P., Picciolini, S., de Rosbo, N. K., Uccelli, A., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1331210 · Cited by 29
Dou, T., Li, J., Zhang, Y., Pei, W., Zhang, B., Wang, B., Wang, Y., & Jia, H. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1368687 · Cited by 29
Chen, C., Wang, J., Zhu, X., Zhang, S., Yuan, X., Hu, J., Liu, C., Liu, L., Zhang, Z., & Li, J. (2025) · Metabolism · doi:10.1016/j.metabol.2025.156289 · Cited by 31
Fu, C., Fu, W., Huang, Z., He, X., Wei, T., Jin, W., Wu, G., Zhao, Z., Guo, K., Yang, J., et al. (2025) · Cancer Research · doi:10.1158/0008-5472.can-25-1693 · Cited by 26
Golla, U., Swagatika, S., Chauhan, S., & Tomar, R. S. (2017) · Oncotarget · doi:10.18632/oncotarget.21416 · Cited by 26
Li, Q., Alsaidan, O. A., Ma, Y., Kim, S., Liu, J., Albers, T., Liu, K., Beharry, Z. M., Zhao, S., Wang, F., et al. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra117.000940 · Cited by 26
Cho, K., Yoon, D., Yu, M., Peachey, N. S., & Ferreira, P. A. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03078-5 · Cited by 27
Mouhid, L., de Cedrón, M. G., García-Carrascosa, E., Reglero, G., Fornari, T., & de Molina, A. R. (2019) · PLoS ONE · doi:10.1371/journal.pone.0214294 · Cited by 26
Lipidomic comparison of 2D and 3D colon cancer cell culture models
Tobias, F., & Hummon, A. B. (2022) · Journal of Mass Spectrometry · doi:10.1002/jms.4880 · Cited by 26
CD36 accelerates the progression of hepatocellular carcinoma by promoting FAs absorption
Tao, L., Ding, X., Yan, L., Xu, G., Zhang, P., Ji, A., & Zhang, L. (2022) · Medical Oncology · doi:10.1007/s12032-022-01808-7 · Cited by 26
Possible Mechanisms of Dark Tea in Cancer Prevention and Management: A Comprehensive Review
Deng, H., Liu, J. S., Xiao, Y., Wu, J., & Jiao, R. (2023) · Nutrients · doi:10.3390/nu15183903 · Cited by 28
Critical roles and clinical perspectives of RNA methylation in cancer
Li, G., Yao, Q., Liu, P., Zhang, H., Liu, Y., Li, S., Shi, Y., Li, Z., & Zhu, W. (2024) · MedComm · doi:10.1002/mco2.559 · Cited by 29
Cholesteryl Esters: Fueling the Fury of Prostate Cancer
Peck, B., & Schulze, A. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.02.012 · Cited by 26
Self-citationThe Various Metabolic Sources of Histone Acetylation
Sebastián, C., & Mostoslavsky, R. (2016) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2016.11.001 · Cited by 26
Liu, S., Liu, X., Wu, F., Zhang, X., Zhang, H., Gao, D., Bi, D., Qu, H., Ge, J., Xu, Y., et al. (2019) · Experimental Cell Research · doi:10.1016/j.yexcr.2019.111558 · Cited by 26
Hao, Q., Diaz, T., Verduzco, A. D. R., Magyar, C. E., Zhong, J., Elshimali, Y., Rettig, M. B., Henning, S. M., Vadgama, J. V., & Wang, P. (2020) · Scientific Reports · doi:10.1038/s41598-020-58354-3 · Cited by 26
Huang, L., Zhang, J., Wei, B., Chen, S., Zhu, S., Qi, W., Pei, X., Li, L., Liu, W., Wang, Y., et al. (2023) · Cell chemical biology · doi:10.1016/j.chembiol.2023.05.003 · Cited by 27
The roles and molecular mechanisms of non-coding RNA in cancer metabolic reprogramming
Li, S., Peng, M., Tan, S., Oyang, L., Lin, J., Xia, L., Wang, J., Wu, N., Jiang, X., Qiu, P., et al. (2024) · Cancer Cell International · doi:10.1186/s12935-023-03186-0 · Cited by 25
Pan, Y., Li, Y., Fan, H., Cui, H., Chen, Z., Wang, Y., Jiang, M., & Wang, G. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117089 · Cited by 25
Metabolic reprogramming in lung cancer and its clinical implication
Huang, Q., Fan, L., Gong, M., Ren, J. T., Chen, C., & Xie, S. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1516650 · Cited by 29
Wang, J., Meng, S., Chen, Y., Wang, H., Hu, W., Liu, S., Huang, L., Xu, J., Li, Q., Wu, X., et al. (2025) · Redox Report · doi:10.1080/13510002.2025.2474897 · Cited by 25
The solid tumor microenvironment and related targeting strategies: a concise review
Wang, Y., Zhou, H., Ju, S., Dong, X., & Zheng, C. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1563858 · Cited by 35
Madiraju, S. R. M., Possik, E., Al‐Mulla, F., Nolan, C. J., & Prentki, M. (2025) · Endocrine Reviews · doi:10.1210/endrev/bnaf033 · Cited by 26
Aberrant fatty acid profile and FFAR4 signaling confer endocrine resistance in breast cancer
Chu, X., Zhou, Q., Xu, Y.-C., Jiang, J., Li, Q., Zhou, Q., Wu, Q., Jin, M., Wang, H., Gu, Y., et al. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1040-3 · Cited by 25
Study of FABP's interactome and detecting new molecular targets in clear cell renal cell carcinoma
Wu, G., Zhang, Z., Tang, Q., Liu, L., Liu, W., Li, Q., & Wang, Q. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.29272 · Cited by 25
Li, J., Xu, J., Zhang, R., Hao, Y., He, J., Chen, Y., Jiao, G., & Abliz, Z. (2020) · Analytical Chemistry · doi:10.1021/acs.analchem.9b05627 · Cited by 25
Shetty, A. B., Nagesh, P. K. B., Setua, S., Hafeez, B. B., Jaggi, M., Yallapu, M. M., & Chauhan, S. C. (2020) · ACS Omega · doi:10.1021/acsomega.0c00793 · Cited by 25
Pathophysiological Integration of Metabolic Reprogramming in Breast Cancer
Corchado‐Cobos, R., García‐Sancha, N., Mendiburu‐Eliçabe, M., Gómez-Vecino, A., Jiménez‐Navas, A., Pérez‐Baena, M. J., Holgado-Madruga, M., Mao, J., Cañueto, J., Castillo‐Lluva, S., et al. (2022) · Cancers · doi:10.3390/cancers14020322 · Cited by 27
Zhao, G., Zhang, R., Huang, F., Dong, L., Liu, L., Jia, X., Chi, J., Ma, Y., Deng, M., Chen, Y., et al. (2022) · Nutrients · doi:10.3390/nu14061277 · Cited by 25
Duan, J., Huang, Z., Nice, E. C., Xie, N., Chen, M., & Huang, C. (2022) · Journal of Advanced Research · doi:10.1016/j.jare.2022.08.007 · Cited by 26
Recent progress of the tumor microenvironmental metabolism in cervical cancer radioresistance
Zhou, J., Lei, N., Tian, W., Guo, R., Chen, M., Qiu, L., Wu, F., Li, Y., & Chang, L. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.999643 · Cited by 26
Stearate‐derived very long‐chain fatty acids are indispensable to tumor growth
Chu, Q., Liu, P., Song, Y., Yang, R., An, J., Zhai, X., Niu, J., Yang, C., & Li, B. (2022) · The EMBO Journal · doi:10.15252/embj.2022111268 · Cited by 24
Azam, A., & Sounni, N. E. (2022) · Cancers · doi:10.3390/cancers14246267 · Cited by 25
PLAGL2 promotes bladder cancer progression via RACGAP1/RhoA GTPase/YAP1 signaling
Chen, H., Yang, W., Li, Y., & Ji, Z. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-05970-2 · Cited by 25
Liu, S., Jiao, B., Zhao, H., Liang, X., Jin, F., Liu, X., & Hu, J. (2023) · Advanced Science · doi:10.1002/advs.202303570 · Cited by 26
Dias, A., Ruiz, N., Couzinet‐Mossion, A., Bertrand, S., Duflos, M., Pouchus, Y. F., Barnathan, G., Nazih, H., & Wielgosz‐Collin, G. (2015) · Marine Drugs · doi:10.3390/md13084934 · Cited by 24
Nishizawa, S., Sumi, H., Satoh, Y., Yamamoto, Y., Kitazawa, S., Honda, K., Araki, H., Kakoi, K., Imamura, K., Sasaki, M., et al. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.03.064 · Cited by 25
PPARγ sumoylation-mediated lipid accumulation in lung cancer
Phan, A. N. H., Vo, V. T. A., Hua, T. N. M., Kim, M.-K., Jo, S., Choi, J.-W., Kim, H.-W., Son, J., Suh, Y., & Jeong, Y. (2017) · Oncotarget · doi:10.18632/oncotarget.19700 · Cited by 26
Adipose Tissue Metabolism and Cancer Progression: Novel Insights from Gut Microbiota?
Jordan, B. F., Gourgue, F., & Cani, P. D. (2017) · Current Pathobiology Reports · doi:10.1007/s40139-017-0154-6 · Cited by 25
Discovery of Novel Selective Acetyl-CoA Carboxylase (ACC) 1 Inhibitors
Mizojiri, R., Asano, M., Tomita, D., Banno, H., Nii, N., Sasaki, M., Sumi, H., Satoh, Y., Yamamoto, Y., Moriya, T., et al. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b01547 · Cited by 25
Elia, J. M., Carbonnelle, D., Logé, C., Ory, L., Huvelin, J., Tannoury, M. Y., Diab‐Assaf, M., Petit, K., & Nazih, H. (2019) · Lipids in Health and Disease · doi:10.1186/s12944-019-1103-7 · Cited by 25
Chen, G., Zhou, G., Lotvola, A., Granneman, J. G., & Wang, J. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra120.014682 · Cited by 24
Emerging role of metabolic reprogramming in hyperoxia-associated neonatal diseases
Sun, T., Yu, H., Li, D., Zhang, H., & Fu, J. (2023) · Redox Biology · doi:10.1016/j.redox.2023.102865 · Cited by 24
Unmasking the Metabolite Signature of Bladder Cancer: A Systematic Review
Pereira, F. M., Domingues, M. R., Vitorino, R. M. P., Guerra, I. M. S., Santos, L. L., Ferreira, J. A., & Ferreira, R. M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25063347 · Cited by 24
Takaichi, M., Tachinami, H., Takatsuka, D., Yonesi, A., Sakurai, K., Rasul, M. I., Imaue, S., Yamada, S., Ruslin, M., Yamazaki, M., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25179438 · Cited by 24
Manley, S., Liu, W., & Welch, D. R. (2017) · Journal of Molecular Medicine · doi:10.1007/s00109-017-1552-2 · Cited by 26
SREBP-2-driven transcriptional activation of human SND1 oncogene
Armengol, S., Arretxe, E., Enzunza, L., Llorente, I., Mendibil, U., Navarro-Imaz, H., Ochoa, B., Chico, Y., & Martínez, M. J. (2017) · Oncotarget · doi:10.18632/oncotarget.22569 · Cited by 24
Characterization of the role of TMEM45A in cancer cell sensitivity to cisplatin
Schmit, K., Chen, J., Ayama-Canden, S., Fransolet, M., Finet, L., Demazy, C., D'Hondt, L. A., Graux, C., & Michiels, C. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-2088-x · Cited by 23
Yu, Y., Gong, L., & Ye, J. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00942 · Cited by 26
Touchefeu, Y., Duchalais, É., Varannes, S. B. D., Alameddine, J., Mirallié, É., Matysiak‐Budnik, T., Bastard, Q. L., Javaudin, F., Rimbert, M., Jotereau, F., et al. (2020) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000001842 · Cited by 24
Shu, C., Zheng, W., Lin, K., Lim, C. M., & Huang, Z. (2021) · Analytical Chemistry · doi:10.1021/acs.analchem.0c03778 · Cited by 22
Breath analysis for the detection of digestive tract malignancies: systematic review
Hintzen, K. F. H., Grote, J., Wintjens, A. G. W. E., Lubbers, T., Eussen, M. M. M., van Schooten, F., Bouvy, N. D., & Peeters, A. (2021) · BJS Open · doi:10.1093/bjsopen/zrab013 · Cited by 25
Lipin-1, a Versatile Regulator of Lipid Homeostasis, Is a Potential Target for Fighting Cancer
Brohée, L., Crémer, J., Colige, A., & Deroanne, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094419 · Cited by 23
Colavita, J. P. M., Mignolli, F., Stoyanoff, T. R., Aguirre, M. V., Balboa, M. A., Balsinde, J., & Rodríguez, J. P. (2021) · Cancers · doi:10.3390/cancers13122962 · Cited by 24
Targeting Nutrient Dependency in Cancer Treatment
Fan, K., Liu, Z., Gao, M., Tu, K., Xu, Q., & Zhang, Y. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.820173 · Cited by 26
Wong, Y., Wang, J., Lim, T. K., Lin, Q., Yap, C. T., & Shen, H. (2022) · PROTEOMICS · doi:10.1002/pmic.202100175 · Cited by 26
Glycyrrhetinic acid restricts mitochondrial energy metabolism by targeting SHMT2
Jin, X., Li, L., Peng, Q., Gan, C., Gao, L. P., He, S., Tan, S., Pu, W., Liu, Y., Gong, Y., et al. (2022) · iScience · doi:10.1016/j.isci.2022.104349 · Cited by 25
Li, C., Chen, S., Jia, W., Li, W., Wei, D., Cao, S., Qian, Y., Guan, R., Liu, H., & Lei, D. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.955614 · Cited by 24
Poddar, A., Rao, S. R., Prithviraj, P., Kannourakis, G., & Jayachandran, A. (2022) · Current Oncology · doi:10.3390/curroncol29100540 · Cited by 24
Wang, X., Xu, B., Du, J., Xia, J., Lei, G., Zhou, C., Hu, J., Zhang, Y., Chen, S., Shao, F., et al. (2022) · Cancer Cell International · doi:10.1186/s12935-022-02739-z · Cited by 25
White spot syndrome virus (WSSV) modulates lipid metabolism in white shrimp
Ng, Y. S., Cheng, C.-S., Ando, M., Tseng, Y.-T., He, S.-T., Li, C.-Y., Cheng, S., Chen, Y.-M., Kumar, R., Liu, C., et al. (2023) · Communications Biology · doi:10.1038/s42003-023-04924-w · Cited by 24
Aberrant Lipid Metabolism in Cancer: Current Status and Emerging Therapeutic Perspectives
Irshad, R., Tabassum, S., & Husain, M. (2023) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026623666230522103321 · Cited by 25
Wang, Z., Yuan, Q., Chen, X., Luo, F., Shi, X., Guo, F., Ren, J., Li, S., & Shang, D. (2023) · Functional & Integrative Genomics · doi:10.1007/s10142-023-01158-1 · Cited by 24
Johansen, M. Ø., Afzal, S., Vedel‐Krogh, S., Nielsen, S. F., Smith, G. D., & Nordestgaard, B. G. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad330 · Cited by 25
Metadata
- Authors
- Currie, E., Schulze, A., Zechner, R., Walther, T. C., & Farese, R. V.
- Affiliations
- University of California, San Francisco (US)
- Cancer Research UK (GB)
- University of Graz (AT)
- Yale University (US)
- Corresponding author
- Farese, Robert V.
- Venue
- Cell Metabolism
- Publisher
- Elsevier BV
- Published
- 2013-08
- Volume
- 18
- Issue
- 2
- Pages
- 153-161
- ISSN
- 1550-4131 (ISSN-L)
- PMC
- PMC3742569
- OpenAlex
- W1980568044
- Cited by
- 2,123
- References
- 82
- Citations by year
- 2026: 118 · 2025: 221 · 2024: 228 · 2023: 221 · 2022: 266 · 2021: 204 · 2020: 193 · 2019: 177 · 2018: 139 · 2017: 122 · 2016: 115 · 2015: 72 · 2014: 41 · 2013: 1
- FWCI
- 6.32
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 370 d)
- doi.org/10.15223/policy-017 (stm-asf)
- doi.org/10.15223/policy-037 (stm-asf)
- doi.org/10.15223/policy-012 (stm-asf)
- doi.org/10.15223/policy-029 (stm-asf)
- doi.org/10.15223/policy-004 (stm-asf)
- Locations
- Cell Metabolism (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute of General Medical Sciences (R01GM099844, R01GM097194)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK056084, P30DK063720, P30DK026743)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Keywords
- fatty acid metabolism, cancer metabolism, lipid metabolism, tumor cell proliferation, fatty acid availability, membrane lipid synthesis
- MeSH terms
- Energy Metabolism, Fatty Acids, Humans, Neoplasms, Cell Proliferation, Lipid Metabolism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
